Tag | Content |
---|
EnhancerAtlas ID | HS131-06294 |
Organism | Homo sapiens |
Tissue/cell | ME-1 |
Coordinate | chr22:29591120-29591900 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ZNF263 | MA0528.1 | chr22:29591861-29591882 | TCCCTCCCCCTCTCTTCCTTT | - | 6.19 | ZNF263 | MA0528.1 | chr22:29591867-29591888 | CCCCTCTCTTCCTTTTCCTCC | - | 6.73 | ZNF263 | MA0528.1 | chr22:29591870-29591891 | CTCTCTTCCTTTTCCTCCCTC | - | 7.21 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_12511 | chr22:29591073-29591299 | CD34_adult | SE_12511 | chr22:29591324-29591769 | CD34_adult | SE_12751 | chr22:29591283-29591709 | CD34_fetal | SE_12751 | chr22:29591788-29592068 | CD34_fetal | SE_53679 | chr22:29591134-29592452 | Spleen |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH22I029195 | chr22 | 29591297 | 29592381 |
|
Enhancer Sequence | AGTCTACATG CAACATGCTT TGGATATAAC CTATGTACTA TTTCTTGATC AGTCTGTGCC 60 AGGCACTGGG CAAAGAAATC CACGTGCCTC ATTTAGATGC TCCTCGTAAC AACTTGCCCT 120 GAGACAAGTA CCCTATCCCC ATTTTCCAGG TGAACACACT GAGGCTCAGA AAGGGGAAGC 180 AATTTGGCCA AGGTTACTCA GTGTCTCACT CAGGAACAGG CAGGATTGAA ACATTTTCCT 240 GGCCAACCTG GGCCTACAGG CCCCACAACG TTAGCCCCAT GTTGGGCCCC TCTTTGACAC 300 CAGGCCACCC TTCTCTTGCC AGAGGAGTCC CAGGTCAGCT GTGCCCCTGG GAATGTCCCA 360 CCAGGGCTGG GCATAGTCAG CCCAGATGGG CCAAGGGCTG CCTGTCAGGA GGGAAAGGGG 420 ACGGTGTAGG GTCCCAGGGC CAATTCTGGA CCTGCACTAT GCTGGTGACT GCCCTAGGGT 480 TCTGCAGCCA GAGTTTGAAT ATGGATGCTG CTAGCTGTGC AACAGTTTGC CACCCTCCCT 540 GGCCTCCCTT TCCTGTGCCA GATCCCTCCT CTGGGGGCAG CTGTGATAAT GCGTGCAGTC 600 ACATAGATAA AGGCTCGAGG CTGACAAGTG GAAAGCAGGT CAGTGGTCGC CCCTTTATCT 660 CTGTTTCTAA CACTGTCTCC TTCTGTGTGT GTGTGTGTGT GTGTGTGTGT CTCCCTATAC 720 TACTGTCTGT CTTTCTGTCT TTCCCTCCCC CTCTCTTCCT TTTCCTCCCT CCGAGGGGTC 780
|